Nov 22 (Reuters) - Britain's competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order during its investigation into Theramex's acquisition of European rights to two of Viatris's women's healthcare product ranges.
The Competition and Markets Authority $(CMA)$ said Viatris breached regulations by failing to obtain its consent before altering key staff and by not reporting the breach.
($1 = 0.7978 pounds)
(Reporting by DhanushVignesh Babu in Bengaluru; Editing by Savio D'Souza)
((DhanushVignesh.Babu@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。